Hepatic cytochrome P-450 expression in tumor necrosis factor-α receptor (p55/p75) knockout mice after endotoxin administration

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 945-950

  Warren, Graham W ^a   Poloyac, Samuel M ^a   Gary, Devin S ^b,c   Mattson, Mark P ^b,c   Blouin, Robert A ^a,b  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ENDOTOXIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; ENZYME METABOLISM; ENZYME REGULATION; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; TRANSGENIC MOUSE;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DOWN-REGULATION; ISOENZYMES; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSOMES, LIVER; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033023322     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Amet Y, Berthou F, Goasduff T, Salaun JP, Le Breton L and Menez JF (1994) Evidence that cytochrome P4502E1 is involved in the (omega-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem Biophys Res Commun 203:1168-1174.
2. Bertini R, Bianchi M, Erroi A, Villa P and Ghezzi P (1989) Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron. J Leukocyte Biol 46:254-262.
3. Beutler B, Milsark IW and Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science (Wash DC) 229:869-871.
4. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW and Mattson MP (1996) Altered neuronal and microglial responses to excitotoxic and ischaemic brain injury in mice lacking TNF receptors. Nat Med 2:788-794.
5. Burke MD, Thompson S, Elcombe CR, Halpert J, Haapatranta T and Mayer RT (1985) Ethoxy-, pentoxy-, and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P450. Biochem Pharmacol 34:3337-3345.
6. Cantoni L, Carelli M, Ghezzi P, Delgado R, Faggioni R and Rizzardini M (1995) Mechanisms of interleukin-2-induced depression of hepatic cytochrome P-450 in mice. Eur J Pharmacol 292:257-263.
7. Carlson TJ and Billings RE (1996) Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Mol Pharmacol 49:796-801.
8. Cassatella MA, Meda L, Bonora S, Ceska M and Constantin G (1993) Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide J Exp Med 178:2207-2211.
9. Chaloupka K, Steinberg M, Santostefano M, Rodriguez LV. Goldstein L and Safe S (1995) Induction of Cyp 1a-2 gene expression by a reconstituted mixture of polynuclear aromatic hydrocarbons in B6C3F1 mice. Ckem Biol Interact 96:207-221.
10. Chen J, Nikolova-Karahashian M, Merrill AH and Morgan ET (1995) Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J. Biol Chem 270:25233-25238.
11. Chen YL, Florentin I, Batt AM, Ferrari L, Giroud JP and Chauvelot-Moachon L (1992) Effect of interleukin-6 on cytochrome P450-dependent mixed function oxidases in the rat. Biochem Pharmacol 44:137-148.
12. Court MH, Von Moltke LL, Shader RI and Greenblatt DJ (1997) Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species. Biopharm Drug Dispos 18:213-226.
13. Crawford EK, Ensor JE, Kalvakolanu I and Hasday JD (1997) The role of 3′ poly(A) tail metabolism in tumor necrosis factor-α regulation. J Biol Chem 272:21120-21127.
14. Cross AS, Sadoff JC, Kelly N, Bernton E and Gemski P (1989) Pretreatment with recombinant murine tumor necrosis factor α/cachectin and murine interleukin 1 α protects mice from lethal bacterial infection. J Exp Med 169:2021-2027.
15. Darnay BG and Aggarwal BB (1997) Early events in TNF signaling: A story of associations and dissociations. J Leukoc Biol 61:559-566.
16. Evans TJ, Strivens E, Carpenter A and Cohen J (1993) Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous gram-negative infection. J Immunol 150: 5033-5040.
17. Feng Y, Tang Y, Guo J and Wang X (1997) Inhibition of LPS-induced TNF-α production by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages. Life Sci 61:PL281-PL287.
18. Freudenberg MA, Keppler D and Galanos C (1986) Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immunol 51:891-895.
19. Freudenberg N, Piotraschke J, Galanos C, Sorg C, Askaryar FA, Klosa B, Usener HU and Freudenberg MA (1992) The role of macrophages in the uptake of endotoxin by the mouse liver. Virch Arch B Cell Pathol 61:343-349.
20. Ghezzi P, Saccardo B, Villa P, Rossi V, Bianchi M and Dinarello CA (1986) Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect Immunol 54:837-840.
21. Giera DG and van Lier RBL (1991) A convenient method for the determination of hepatic lauric acid ω-oxidation based on solvent partition. Fundam Appl Toxicol 16:348-355.
22. Gruss HJ and Dower SK (1995) The TNF ligand superfamily and its relevance for human diseases. Cytokines Mol Ther 1:75-105.
23. Halpert JR, Guengerich FP, Bend JR and Correia MA (1994) Contemporary issues in toxicology: Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol 125: 163-175.
24. Harbrecht BG, Di Silvio M, Demetrius AJ, Simmons RL and Billiar TR (1994) Tumor necrosis factor-α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 20:1055-1060.
25. Heller RA and Kronke M (1994) Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 126:5-9.
26. Hiratsuka M, Matsuura T, Watanabe E, Sato M and Suzuki Y (1996a) Sex differences in constitutive level of renal lauric acid hydroxylase activities and CYP4A-related proteins in mice. Biol Pharm Bull 19:512-517.
27. Hiratsuka M, MatsuuraT, Watanabe E, Sato M and Suzuki Y (1996b) Sex and strain differences in constitutive expression of fatty acid omega-hydroxylase (CYP4A-related proteins) in mice. J Biochem (Tokyo) 119:340-345.
28. Honkakoski P, Moore R, Gynther J and Negishi M (1992) Regulation of the mouse liver cytochrome P450 2B subfamily by sex hormones and phenobarbital. Biochem J 285:979-983.
29. Ioannides C (1996) Cytochromes P450: Metabolic and Toxicological Aspects. CRC Press, New York.
30. Iwasaki M, Lindberg RL, Juvonen RO and Negishi M (1993) Site directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): Role of residue-209 in determining steroid-cytochrome P-450 interaction. Biochem J 291: 569-573.
31. Jayyosi Z, Knoble D, Mue M, Erick J, Thomas PE and Kelley M (1995) Cytochrome P450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. J Pharmacol Exp Ther 273:1156-1161.
32. Jeong HG, Yun CH, Jeon YJ, Lee SS and Yang KH (1995) Suppression of cytochrome P450 (Cyp1a-1) induction in mouse hepatoma Hepa-1C1C7 cells by methoxsalen. Biochim Biophys Res Commun 208:1124-1130.
33. Khatsenko OG, Gross SS, Rifkind AB and Vane JR (1993) Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA 90:11147-11151.
34. Liang JF and Akaike T (1997) Role of metabolic intermediates in lipopolysaccharide/ cytokine-mediated production of nitric oxide in isolated mouse hepatocytes. Biochem Biophys Res Commun 236:379-382.
35. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
36. Memon RA, Grunfeld C, Moser AH and Feingold KR (1993) Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 132:2246-2253.
37. Monshouwer M, McLellan RA, Delaporte E, Witkamp RF, Van Miert ASJPAM and Renton KW (1996) Differential effect of pentoxifylline on lipopolysaccharideinduced downregulation of cytochrome P450. Biochem Pharmacol 52:1195-1200.
38. Morgan ET (1993) Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo: Independence from the hypothalmic-pituitary axis. Biochem Pharmacol 45:415-419.
39. Morgan ET, Thomas KB, Swanson R, Vales T, Hwang J and Wright K (1994) Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochim Biophys Acta 1219:475-483.
40. Nadin L, Butler AM, Farrell GC and Murray M (1995) Pretranslational downregulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor α. Gastroenterology 109:198-205.
41. Omura T and Sato R (1964) The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
42. Peter R, Bocker R, Beaune P, Iwasaki M, Guengerich FP and Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P4502E1. Chem Res Toxicol 3:566-573.
43. Pous C, Giroud JP, Damais C, Raichvarg D and Chauvelot-Moachon L (1990) Effect of recombinant human interleukin-1β and tumor necrosis factor α on liver cytochrome P-450 and serum α-1-acid glycoprotein concentrations in the rat. Drug Metab Dispos 18:467-470.
44. Sauer A, Hartung T, Aigner J and Wendel A (1996) Endotoxin-inducible granulocyte-mediated hepatotoxicity requires adhesion and serine protease release. J Leukocyte Biol 60:633-643.
45. Sewer MB, Koop DR and Morgan ET (1996) Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450. Drug Metab Dispos 24:401-407.
46. Sewer MB and Morgan ET (1997) Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1β and endotoxin in primary rat hepatocytes. Biochem Pharmacol 54:729-737.
47. Shedlofsky SI, Israel BC, McClain CJ, Hill DB and Blouin RA (1994) Endotoxin administration to humans inhibits cytochrome P450-mediated drug metabolism. J Clin Invest 94:2209-2214.
48. Sonderfan AJ, Arlotto P, Dutton DR, McMillen SK and Parkinson A (1987) Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P450. Arch Biochem Biophys 255:27-41.
49. Wink DA, Osawa Y, Darbyshire JF, Jones CR, Eshenaur SC and Nims RW (1993) Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys 300:115-123.
50. Wong G, Itakura T, Kawajiri K, Show L and Negishi M (1989) Gene family of male-specific testosterone 16 alpha-hydroxylase (C-P-450(16 alpha)) in mice: Organization, differential regulation, and chromosomal localization. J Biol Chem 264:2920-2927
51. Wong G, Kawajiri K and Negishi M (1987) Gene family of male-specific testosterone 16 alpha-hydroxylase (C-P-450(16)alpha) in mouse liver: cDNA sequences, neonatal imprinting, and reversible regulation by androgen. Biochemistry 26:8683-8690.
52. Yanagimoto T, Itoh S, Sawada M, Hashimoto H and Kamataki T (1994) Molecular cloning and functional expression of a mouse cytochrome P-450 (Cyp3a-13): Examination of Cyp3a-13 enzyme to activate aflatoxin B1 (AFB1). Biochim Biophys Acta 1201:405-410.
53. Zheng L, Fisher D, Miller RE, Peschon J, Lynch DH and Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumor necrosis factor. Nature (London) 377:348-351.